New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer
Oncology March 12,2024
Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer
Oncology March 12,2024
Fighting cancer one cell at a time

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c
Oncology March 12,2024
Fighting cancer one cell at a time

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c
Oncology March 12,2024
Meningioma molecular profile reliably predicts tumor recurrence

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The
Oncology March 12,2024
Meningioma molecular profile reliably predicts tumor recurrence

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The
Oncology March 12,2024
Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u
Oncology March 12,2024
Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u
Oncology March 12,2024
Generating large numbers of universal immune cells could transform cancer immunotherapy

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d
Oncology March 12,2024
Generating large numbers of universal immune cells could transform cancer immunotherapy

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d
Oncology March 12,2024
New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainNeuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.For t
Oncology March 12,2024
New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainNeuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.For t
Oncology March 12,2024
New health guidance on breast cancer

New health guidance on breast cancer

by Queen Mary, University of LondonCredit: Queen Mary, University of LondonIn their draft guidance, the National Institute for Health and Care Excellence (NICE) said that postmenopausal women wit
Oncology March 12,2024
New health guidance on breast cancer

New health guidance on breast cancer

by Queen Mary, University of LondonCredit: Queen Mary, University of LondonIn their draft guidance, the National Institute for Health and Care Excellence (NICE) said that postmenopausal women wit
Oncology March 12,2024
Facts women and men should know about cervical cancer

Facts women and men should know about cervical cancer

by Florida International UniversityCredit: Florida International UniversityJanuary is Cervical Cancer Awareness month and the message from the Centers from Disease Control and Prevention is that
Oncology March 12,2024
Facts women and men should know about cervical cancer

Facts women and men should know about cervical cancer

by Florida International UniversityCredit: Florida International UniversityJanuary is Cervical Cancer Awareness month and the message from the Centers from Disease Control and Prevention is that
Oncology March 12,2024
First major study of proteins in patients with acute lymphoblastic leukaemia

First major study of proteins in patients with acute lymphoblastic leukaemia

by Lund UniversityA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaThe most common form of childhood ca
Oncology March 12,2024
First major study of proteins in patients with acute lymphoblastic leukaemia

First major study of proteins in patients with acute lymphoblastic leukaemia

by Lund UniversityA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaThe most common form of childhood ca
Oncology March 12,2024
Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m
Oncology March 12,2024
Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m
Oncology March 12,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com